ZR2 Bioenergy Share Price
114.55+2.05 (+1.82%)
-71.78% past 1 Year
Gujchem Distillers India Limited (GDIL) was initially set up as a proprietary concern in 1911. It was later converted into a private limited Company as Sardesai Brothers Private Limited in
Corporate filings & documents
Announcements
This is to inform that the Board of Directors at its meeting held today i.e. Friday August 14 2026 inter-alia have considered and approved the following: 1. Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026. In this regard we enclose the following: i. Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026. ii. Limited Review Report of the Company for the quarter ended June 30 2026.
2 weeks agoThis is to inform that the Board of Directors at its meeting held today i.e. Friday August 14 2026 inter-alia have considered and approved the following: 1. Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026. In this regard we enclose the following: i. Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026. ii. Limited Review Report of the Company for the quarter ended June 30 2026.
2 weeks agoBOARD MEETING OUTCOME FOR APPROVING AND CONSIDERATION OF THE UNAUDITED FINANCIAL YEAR ENDED 30TH JUNE 2026.
2 weeks agoBOARD MEETING OUTCOME FOR APPROVING AND CONSIDERATION OF THE UNAUDITED FINANCIAL YEAR ENDED 30TH JUNE 2026.
2 weeks agoPursuant to Regulation 32 of the Securities and Exchange Board of India ("SEBI") (Listing Obligations and Disclosure Requirements) Regulations 2015 ("Listing Regulations") read with Regulation 173A of SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 we have enclosed herewith the Monitoring Agency Report for the quarter ended June 30 2026 issued by Crisil Ratings Limited ("Monitoring Agency") in respect of the utilization of proceeds raised through Preferential Issue by the Company duly reviewed by the Audit Committee and taken on record by the Board of Directors.
2 weeks agoPursuant to Regulation 32 of the Securities and Exchange Board of India ("SEBI") (Listing Obligations and Disclosure Requirements) Regulations 2015 ("Listing Regulations") read with Regulation 173A of SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 we have enclosed herewith the Monitoring Agency Report for the quarter ended June 30 2026 issued by Crisil Ratings Limited ("Monitoring Agency") in respect of the utilization of proceeds raised through Preferential Issue by the Company duly reviewed by the Audit Committee and taken on record by the Board of Directors.
2 weeks agoPursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find enclosed herewith a confirmation certificate received from MUFG Intime India Private Limited the Registrar and Transfer Agent of the Company for quarter ended June 30 2026.
1 month agoPursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find enclosed herewith a confirmation certificate received from MUFG Intime India Private Limited the Registrar and Transfer Agent of the Company for quarter ended June 30 2026.
1 month agoWe inform you that in accordance with the Companys Code of Conduct for Insider Trading (Code) read with applicable provisions of SEBI (PIT) Regulation 2015 the Trading Window for dealing in the shares of the Company will remain closed with effect from Wednesday July 01 2026 till 48 hours after the declaration of the Unaudited Standalone and Consolidated Financial Results for quarter ended on June 30 2026.
2 months agoWe inform you that in accordance with the Companys Code of Conduct for Insider Trading (Code) read with applicable provisions of SEBI (PIT) Regulation 2015 the Trading Window for dealing in the shares of the Company will remain closed with effect from Wednesday July 01 2026 till 48 hours after the declaration of the Unaudited Standalone and Consolidated Financial Results for quarter ended on June 30 2026.
2 months agoThis is to inform that the Board of Directors at its meeting held today i.e. Friday May 29 2026 inter-alia have considered and approved the following: 1. Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31 2026.
3 months agoThis is to inform that the Board of Directors at its meeting held today i.e. Friday May 29 2026 inter-alia have considered and approved the following: 1. Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31 2026.
3 months agoThis is to inform that the Board of Directors at its meeting held today i.e. Friday May 29 2026 inter-alia have considered and approved the following:1. Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31 2026.
3 months agoThis is to inform that the Board of Directors at its meeting held today i.e. Friday May 29 2026 inter-alia have considered and approved the following:1. Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31 2026.
3 months agoThe Exchange has sought clarification from ZR2 Bioenergy Limited with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.
3 months agoThe Exchange has sought clarification from ZR2 Bioenergy Limited with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.
3 months agoZR2 Bioenergy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve In compliance with Regulation 29 and other applicable provisions of LODR Regulations this is to inform that 01/2026-27 meeting of the Board of Directors of the Company is scheduled to be held on Friday May 29 2026 to consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31 2026
3 months agoZR2 Bioenergy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve In compliance with Regulation 29 and other applicable provisions of LODR Regulations this is to inform that 01/2026-27 meeting of the Board of Directors of the Company is scheduled to be held on Friday May 29 2026 to consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31 2026
3 months agoMONITORING AGENCY REPORT FOR THE QUARTER ENDED 31ST MARCH 2026
3 months agoMONITORING AGENCY REPORT FOR THE QUARTER ENDED 31ST MARCH 2026
3 months agoDear Sir/Madam We write to inform you that in accordance with the Companys Code of Conduct for Insider Trading (Code) read with applicable provisions of SEBI (Prohibition of Insider Trading) Regulation 2015 the Trading Window for dealing in securities of the Company by Designated Persons and their immediate relatives shall remain closed with effect from April 01 2026 till 48 hours after the approval and dissemination of Audited Financial Results for the quarter and financial year ended March 31 2026 to the Stock Exchanges.
4 months agoDear Sir/Madam We write to inform you that in accordance with the Companys Code of Conduct for Insider Trading (Code) read with applicable provisions of SEBI (Prohibition of Insider Trading) Regulation 2015 the Trading Window for dealing in securities of the Company by Designated Persons and their immediate relatives shall remain closed with effect from April 01 2026 till 48 hours after the approval and dissemination of Audited Financial Results for the quarter and financial year ended March 31 2026 to the Stock Exchanges.
4 months agoDear Sir/Madam Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find enclosed herewith a confirmation certificate received from MUFG Intime India Private Limited the Registrar and Transfer Agent of the Company for quarter ended March 31 2026. Please take the above on record.
4 months agoDear Sir/Madam Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find enclosed herewith a confirmation certificate received from MUFG Intime India Private Limited the Registrar and Transfer Agent of the Company for quarter ended March 31 2026. Please take the above on record.
4 months agoThe Exchange has sought clarification from ZR2 Bioenergy Ltd on April 8 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
4 months agoThe Exchange has sought clarification from ZR2 Bioenergy Ltd on April 8 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
4 months agoThe Exchange has sought clarification from ZR2 Bioenergy Ltd on March 17 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
5 months agoThis is in furtherance of the intimation given by the Company on May 10 2024 wherein we had informed you that the Company had allotted 2 59 22 000 convertible warrants of the Company on a Preferential Basis to Acquirer alias Proposed Promoter and Strategic Investors (Non-Promoters) for an issue price of Rs. 65/- each aggregating to the amount of Rs. 168 49 30 000/-. Thereafter out of which Rs. 42 12 32 500/- (Rupees Forty-Two Crores Twelve Lakhs Thirty-Two Thousand Five Hundred) has already been received as the initial subscription amount at the time of allotment of the warrants.
6 months agoAllotment of 1 23 50 000 Additional Equity Shares (on account of conversion of Compulsorily Convertible Debentures (CCDs) into equity shares.
6 months agoAllotment of 1 23 50 000 Additional Equity Shares (on account of conversion of Compulsorily Convertible Debentures (CCDs) into equity shares.
6 months agoMonitoring Agency Report for the quarter ended December 31 2025 in respect of Funds raised by issuance of Convertible Warrants and Compulsory Convertible Debentures on a Preferential Basis
6 months agoMonitoring Agency Report for the quarter ended December 31 2025 in respect of Funds raised by issuance of Convertible Warrants and Compulsory Convertible Debentures on a Preferential Basis
6 months agoOutcome of Board Meeting held on February 14 2026 and Submission of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31 2025 as per SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015.
6 months agoOutcome of Board Meeting held on February 14 2026 and Submission of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31 2025 as per SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015.
6 months agoOutcome of Board Meeting held on February 14 2026 and Submission of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31 2025 as per SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015.
6 months agoOutcome of Board Meeting held on February 14 2026 and Submission of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31 2025 as per SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015.
6 months agoCertificate under Reg. 74(5) of SEBI (DP) Regulation 2018
7 months agoIntimation of Trading Window Closure
8 months agoResignation of Company Secretary & Compliance Officer
8 months agoSubmission of Newspaper Advertisement issued for the publication of Unaudited (Standalone and Consolidated) Financial Results for the quarter ended September 30 2025
9 months agoSubmission of Newspaper Advertisement issued for the publication of Unaudited (Standalone and Consolidated) Financial Results for the quarter ended September 30 2025
9 months agoMonitoring Agency Report for the quarter ended September 30 2025
9 months agoPublication of Unaudited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30 2025 along with Limited Review Report thereon
9 months agoOutcome of the Board Meeting held on November 14 2025 to consider and approve un audited (Standalone and Consolidated) Financials of the Company for the quarter and half year ended September 30 2025
9 months agoZR2 Bioenergy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve unaudited (standalone and consolidated) Financial Statement for the quarter ended September 30 2025
9 months agoCompliance Certificate under Reg. 74 (5) of SEBI (DP) Regulation 2018 for the quarter ended September 30 2025
10 months agoAppointment of Secretarial Auditor
11 months agoScrutinizers Report on voting at the 86th Annual General Meeting of the Company held on September 29 2025
11 months agoProceeding of 86th Annual General Meeting of the Company held on September 29 2025
11 months agoIntimation of Trading Window Closure for the quarter ended September 30 2025
11 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2025-09-10
Dividend
0.1
Company details
Registered office
Survey N. 146, Plot No. 314 307, 3 Floor, Ashirwad Paras-1 S. G. Highway, Makarba Ahmedabad Gujarat PIN: 380051 Tel No: 9998960235 Fax No: NULL Email: [email protected] / [email protected] Internet: www.gujchemdistillers.com
Registrars
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I)Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura, Ahmedabad - 380009 506-508, 5th Floor, Amaranth Business Complex - I (ABC - I) Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road Navrangpura PIN: Tel No: NULL Fax No: NULL Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Jimmy Olsson, Chairman & Managing Director
Jimmy Olsson, Chairman & Managing Director
Nilesh Jain, Non Independent & Non Executive Director
Nirupama Charuhas Khandke, Non Executive Independent Director
Sunil Kondiba Kalhapure, Non Executive Independent Director
Details
BSE 506640
NSE NULL
ISIN INE218N01021